Aberdeen University Featured PhD Programmes
Heriot-Watt University Featured PhD Programmes
Ulster University Featured PhD Programmes
Newcastle University Featured PhD Programmes
University of Reading Featured PhD Programmes
"pharmaceutical" AND "sci…×
10 miles

Cancer / Oncology (pharmaceutical sciences) PhD Projects, Programs & Scholarships

We have 15 Cancer / Oncology (pharmaceutical sciences) PhD Projects, Programs & Scholarships

  • "pharmaceutical" AND "sciences" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 1 to 10 of 15
  Discovery of novel cancer immunotherapeutic agents
  Dr Y Mehellou
Applications accepted all year round

Funding Type

PhD Type

Although cancer therapeutics, mainly chemotherapy and radiotherapy, have been extremely useful in the treatment of cancer, this disease is still associated with high morbidity and mortality.
  Designing novel composite polysaccharide nanoparticles for combined diagnosis and treatment of cancers
  Dr E Barbu, Dr A Lalatsa
Applications accepted all year round

Funding Type

PhD Type

Cancer continues to impose a vast burden with regard to financial costs as well as human suffering but the progress in its treatment is hindered by the limited selectivity and significant side-effects that the current chemotherapy demonstrates, representing a major challenge for modern drug delivery.
  Fostering development of ‘smart’, responsive therapeutics against cancer-related microRNAs.
  Dr E Bichenkova, Prof D Clarke, Dr H Aojula
Applications accepted all year round

Funding Type

PhD Type

Short functional non-coding microRNAs are implicated in many types of cancer, and thus can be used as biological targets for development of more selective and powerful anticancer therapies.
  EPSRC Centre for Doctoral Training in Sustainable Approaches to Biomedical Science: Responsible and Reproducible Research - SABS

Funding Type

PhD Type

Good degree in the Physical or Life Sciences? Interested in biological or medical research? We offer fully-funded PhD places across the Oxford Doctoral Training Centre programmes.
  Long-acting drug delivery from intravaginal rings for treatment of cervical intraepithelial neoplasia
  Prof K Malcolm, Dr P Boyd
Applications accepted all year round

Funding Type

PhD Type

Building on our world-renowned expertise in vaginal drug delivery, the aim of this project is to develop a long-acting vaginal ring device for treatment of cervical intraepithelial neoplasia.
  Nano-engineered Delivery Systems for the Targeted Delivery of Oncology Drugs for Non-Small Cell Lung Cancer
  Dr H McCarthy, Dr N Buckley
Applications accepted all year round

Funding Type

PhD Type

Lung cancer is the most common cancer worldwide accounting for 11.6% of the global burden. The standard of care (SoC) chemotherapy typically involves a ‘cocktail’ of drugs which confer debilitating side-effects, resulting in sub-optimal dosing with a reduced clinical efficacy.
  Personalised Medicine for Breast and Ovarian Cancer
  Dr N Buckley, Dr H McCarthy
Applications accepted all year round

Funding Type

PhD Type

One in two people will develop cancer in their lifetime and it is a leading cause of death. While significant progress has been made in the treatment of some cancers, there still remain some forms of the disease with limited treatment options and poor outcome.
  Dissecting novel mechanisms of cysteine protease biology in tumourigenesis
  Dr R Burden, Prof C Scott
Applications accepted all year round

Funding Type

PhD Type

Proteases are known for their role in facilitating tumour development, primarily through processes such as proliferation and invasion.
  To develop an allosteric inhibitor of HDAC6 inhibition in cancer
  Dr F Furlong, Dr I Tikhonova
Applications accepted all year round

Funding Type

PhD Type

The HDAC6 protein is upregulated in cancer and associated with increased proliferation and metastasis. Several HDAC6 inhibitors have been developed and are in clinical trials.
  USP17 as a cancer therapeutic target
  Dr J Burrows
Applications accepted all year round

Funding Type

PhD Type

USP17 is over-expressed in a range of primary tumours including NSCLC, breast, colorectal, cervical, ovarian and osteosarcoma and its depletion has been shown to block the growth of cells from all these cancer types.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.